9 juill. 2018 - FDA hosted a public meeting on Patient-Focused Drug Development for chronic pain to hearing patients’ perspectives on chronic pain, views on treatment approaches, and challenges or barriers to accessing treatments for chronic pain.

Ajouté au bande de temps:

13 nov. 2018

0

0

323

Opioids and the FDA

Date: